Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Zhe Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4726-2940; OpenAlex author ID A5100462397. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer. Co-author DOI 10.1155/2022/5514715↗
  2. microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1. Co-author DOI 10.3978/j.issn.1000-9604.2015.04.07↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junming Xu · 1 shared paper, 2022 · strength 0.15
  2. Xinxue Zhang · 1 shared paper, 2022 · strength 0.15
  3. Xin Zhao · 1 shared paper, 2022 · strength 0.15
  4. Qiang He · 1 shared paper, 2022 · strength 0.15
  5. Qing Chen · 1 shared paper, 2022 · strength 0.15
  6. Zhangyong Ren · 1 shared paper, 2022 · strength 0.15
  7. Ren Lang · 1 shared paper, 2022 · strength 0.15
  8. Ruixia Du · 1 shared paper, 2015 · strength 0.06
  9. Kejian Guo · 1 shared paper, 2015 · strength 0.06
  10. Jin Long · 1 shared paper, 2015 · strength 0.06
  11. Chunlin Ge · 1 shared paper, 2015 · strength 0.06
  12. Yuanhong Xu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.